United States · 
Who invested in Imbria Pharmaceuticals?
Imbria Pharmaceuticals's investors include RA Capital Management, Catalio Capital Management, SV Health Investors and Sanofi.
2026
$59MSeries B?Venture
United States · Venture startup
Who invested in Imbria Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$59Mraised across 2 rounds since 2025, from 2 sources
- Latest round
- VentureNov 2025
- Biggest round
- $59MSeries B · Apr 2025
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $59M Apr 2025
- Biggest round
- $59M Series B · Apr 2025
- Between rounds
- 7 months from the last two
The rounds
- Nov 2025VentureAmount undisclosed1 new3 returning
Source recordedSEC filing: $67M sold, first sale Mar 2025
- Apr 2025Series B$59M3 new
Source recordedSEC filing: $59M sold, first sale Mar 2025
Founders and team
From Imbria Pharmaceuticals's own website: 6 on the team.
- Alvin ShihChief Executive Officer and Board Member
- Albert KimChief Medical Officer
- Arash YavariChief Scientific Officer
- Komal JoshiChief Financial Officer
- Sophie KimClinical Trial Manager
- Vanessa MurraySenior Director, Clinical Operations
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
SV Health InvestorsVC firm2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Imbria Pharmaceuticals
How much has Imbria Pharmaceuticals raised?
Imbria Pharmaceuticals has raised $59M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did Imbria Pharmaceuticals last raise?
Imbria Pharmaceuticals's most recent round was a Venture in Nov 2025.
What was Imbria Pharmaceuticals's biggest round?
Imbria Pharmaceuticals's largest round on record is $59M (Series B), in Apr 2025.
Who backed Imbria Pharmaceuticals first?
Imbria Pharmaceuticals's first round on record, in Apr 2025, was backed by RA Capital Management, Catalio Capital Management and SV Health Investors.
What stage is Imbria Pharmaceuticals at?
Imbria Pharmaceuticals's latest named round is a Venture, in Nov 2025.
Where is Imbria Pharmaceuticals based?
Imbria Pharmaceuticals is based in the United States.
Companies like Imbria Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.